Low-Gradient, Low-Flow Severe Aortic Stenosis With Preserved Left Ventricular Ejection Fraction Characteristics, Outcome, and Implications for Surgery by Tribouilloy, Christophe et al.
J O U R N A L O F T H E AM E R I C A N C O L L E G E O F C A R D I O L O G Y V O L . 6 5 , N O . 1 , 2 0 1 5
ª 2 0 1 5 B Y T H E AM E R I C A N C O L L E G E O F C A R D I O L O G Y F O U N DA T I O N I S S N 0 7 3 5 - 1 0 9 7 / $ 3 6 . 0 0
P U B L I S H E D B Y E L S E V I E R I N C . h t t p : / / d x . d o i . o r g / 1 0 . 1 0 1 6 / j . j a c c . 2 0 1 4 . 0 9 . 0 8 0Low-Gradient, Low-Flow Severe
Aortic Stenosis With Preserved Left
Ventricular Ejection Fraction
Characteristics, Outcome, and Implications for SurgeryChristophe Tribouilloy, MD, PHD,*y Dan Rusinaru, MD, PHD,*z Sylvestre Maréchaux, MD, PHD,x
Anne-Laure Castel, MD,* Nicolas Debry, MD,x Julien Maizel, MD, PHD,y Romuald Mentaverri, PHARMD, PHD,y
Said Kamel, PHARMD, PHD,y Michel Slama, MD, PHD,y Franck Lévy, MD*yABSTRACTFro
Pic
Hô
ha
Lis
Yo
MaBACKGROUND Severe low-gradient, low-ﬂow (LG/LF) aortic stenosis with preserved left ventricular ejection fraction
(EF) has been described as a more advanced form of aortic stenosis. However, the natural history and need for surgery in
patients with LG/LF aortic stenosis remain subjects of intense debate.
OBJECTIVES We sought to investigate the outcome of LG/LF aortic stenosis in comparison with moderate aortic
stenosis and with high-gradient (HG) aortic stenosis in a real-world study, in the context of routine practice.
METHODS This analysis included 809 patients (ages 75  12 years) diagnosed with aortic stenosis and preserved EF
($50%). Patients were divided into 4 groups: mild-to-moderate aortic stenosis; HG aortic stenosis; LG/LF aortic stenosis;
and low-gradient, normal-ﬂow (LG/NF) aortic stenosis.
RESULTS Compared with mild-to-moderate aortic stenosis patients, LG/LF aortic stenosis patients had smaller valve
areas and stroke volumes, higher mean gradients, and comparable degrees of ventricular hypertrophy. Under medical
management (22.8 months; range 7 to 53 months), compared with mild-to-moderate aortic stenosis patients, HG aortic
stenosis patients were at higher risk of death (adjusted hazard ratio [HR]: 1.47; 95% conﬁdence interval [CI]: 1.03 to 2.07),
whereas LG/LF aortic stenosis patients did not have an excess mortality risk (adjusted HR: 0.88; 95% CI: 0.53 to 1.48).
During the entire (39.0 months; range 11 to 69 months) follow-up (with medical and surgical management), the mortality
risk associated with LG/LF aortic stenosis was close to that ofmild-to-moderate aortic stenosis (adjusted HR: 0.96; 95%CI:
0.58 to 1.53), whereas the excess risk of death associated with HG aortic stenosis was conﬁrmed (adjusted HR: 1.74; 95%CI:
1.27 to 2.39). The beneﬁt associated with aortic valve replacement was conﬁned to the HG aortic stenosis group (adjusted
HR: 0.29; 95% CI: 0.18 to 0.46) and was not observed for LG/LF aortic stenosis (adjusted HR: 0.75; 95% CI: 0.14 to 4.05).
CONCLUSIONS In this study, the outcome of severe LG/LF aortic stenosis with preserved EF was similar to that of mild-
to-moderate aortic stenosis and was not favorably inﬂuenced by aortic surgery. Further research is needed to better
understand the natural history and the progression of LG/LF aortic stenosis. (J Am Coll Cardiol 2015;65:55–66)
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ABBR EV I A T I ON S
AND ACRONYMS
AVA = aortic valve area
AVR = aortic valve
replacement
CAD = coronary artery disease
EF = ejection fraction
HG = high-gradient
LG/LF = low-gradient/
low-ﬂow
LG/NF = low-gradient/
normal-ﬂow
MDG = mean Doppler gradient
SV = stroke volume
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56area and errors in measurement of AVA or
Doppler parameters, this discordance may
reﬂect a low stroke volume (SV) index, despite
a normal EF (paradoxical “low-ﬂow”) (8,9).
Patients with low-gradient/low-ﬂow (LG/LF)
aortic stenosis have been reported to have
small ventricular cavities (3,8), severe concen-
tric hypertrophy (3,8), increased afterload
(10,11), restrictive physiology (8), subtle sys-
tolic dysfunction (12), and increased subendo-
cardial myocardial ﬁbrosis (13). These features
have been interpreted as markers of a more
advanced disease, leading to poor prognosis
under conservative therapy. Survival analyses
of limited patient numbers suggest that LG/LFaortic stenosis is associated with greater mortality
risk than high-gradient (HG) severe aortic stenosis
(3–5,7,8), and that surgery might be beneﬁcial in this
subset of patients. Therefore, guidelines recommend
(class IIa recommendation) aortic valve replacement
(AVR) in symptomatic patients with LG/LF aortic ste-
nosis when documented valvular obstruction is the
most probable cause of symptoms (2).SEE PAGE 67The view that LG/LF aortic stenosis with preserved EF
represents a more advanced form of the disease with
pejorative outcome has been questioned by a sub-
analysis of the SEAS (Simvastatin and Ezetimibe in
Aortic Stenosis) trial (14) and by a recent single-center
European cohort study (15). Consistently, magnetic
resonance data in LG aortic stenosis show larger AVAs,
less hypertrophy, and similar focal ﬁbrosis compared
with HG aortic stenosis (16). These recent results raise
doubts about whether LG/LF aortic stenosis with pre-
served EF truly represents a severe form of aortic ste-
nosis with poor prognosis and increased risk of death
when treatedmedically. Moreover, the impact of AVR in
LG/LF aortic stenosis needs to be better deﬁned to avoid
unnecessary and potentially dangerous procedures.
The basis for the present study is the consecutive
experience with aortic stenosis at the echocardiogra-
phy laboratories of 2-F tertiary centers (Amiens and
Lille) between 2000 and 2012. The aims of this anal-
ysis are 3-fold: 1) to establish the relation between
LG/LF aortic stenosis and outcome, regardless of cli-
nical management; 2) to compare the outcomes of LG
aortic stenosis, HG aortic stenosis, and moderate
aortic stenosis; and 3) to understand the impact of
AVR in these subsets of patients.
METHODS
STUDY DESIGN. Consecutive patients $18 years of
age diagnosed with mild or more than mild aorticstenosis (aortic valve calciﬁcation with reduction
in systolic movements and AVA <2 cm2) and an EF
of $50% (1) who were managed medically for at least
3 months after diagnosis were prospectively identi-
ﬁed and included in an electronic database. We
excluded patients with the following: 1) more than
mild aortic and/or mitral regurgitation; 2) prosthetic
valves, congenital heart disease, supravalvular or
subvalvular aortic stenosis, or dynamic left ventric-
ular outﬂow tract obstruction; 3) an EF <50%; and
4) patients who denied authorization for research
participation. We enrolled 898 patients. Subse-
quently, 89 were excluded because of missing data
(n ¼ 83) or absence of follow-up (n ¼ 6). Patients were
retrospectively classiﬁed into 3 groups: mild-to-
moderate aortic stenosis (AVA $1 cm2 or indexed
AVA $0.6 cm2, and MDG <40 mm Hg; n ¼ 420); LG
aortic stenosis (AVA <1 cm2, indexed AVA <0.6 cm2,
and MDG <40 mm Hg; n ¼ 142); and HG aortic ste-
nosis (AVA <1 cm2, indexed AVA <0.6 cm2, and
MDG $40 mm Hg, n ¼ 247). LG aortic stenosis
was further divided according to the SV index in
LG/LF aortic stenosis (n ¼ 57) when the index SV
was <35 ml/m2, and low-gradient, normal-ﬂow
(LG/NF) (n ¼ 85) aortic stenosis when index SV was
$35 ml/m2 (3,4).
An index summating the patient’s individual
comorbidities was calculated (17). Coronary artery
disease (CAD) was deﬁned by the presence of a
documented history of acute coronary syndromes,
CAD previously conﬁrmed by coronary angiography,
or history of coronary revascularization.
We obtained institutional review board authoriza-
tions before conducting the study. The study was
conducted in accordance with institutional policies,
national legal requirements, and the revised Decla-
ration of Helsinki.
ECHOCARDIOGRAPHY. All patients underwent a
comprehensive Doppler echocardiographic study,
using commercially available ultrasound systems.
Peak aortic velocity was recorded using continuous-
wave Doppler in several acoustic windows (apical
5-chamber view, right parasternal, suprasternal,
epigastric). AVA was calculated by the continuity
equation and indexed for body surface area. SV
was calculated by multiplying the area of the left
ventricular outﬂow tract by the outﬂow tract time–
velocity integral (3). When patients were in sinus
rhythm, 3 cardiac cycles were averaged for all
measures. For patients in atrial ﬁbrillation, 5 car-
diac cycles were averaged. EF was calculated using
Simpson’s biplane method. Left ventricular mass
was estimated by the formula on the basis
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57of linear measurements and indexed for body
surface area.
CLINICAL DECISION AND FOLLOW-UP. After initial
medical management, treatment was either conser-
vative or surgical, as deemed appropriate by the
patient’s personal physician. The majority of pa-
tients were followed by clinical consultation and
echocardiography in the outpatient clinics of the 2
tertiary centers. Others were followed in public
hospitals or private practices by referring cardiolo-
gists working with the tertiary centers. Information
on follow-up was retrospectively obtained by direct
patient interview or by repeated follow-up letters
and questionnaires. Median follow-up with medical
management was 22.8 months (range: 7 to 53 months).
Median overall follow-up was 39.0 months (range:
11 to 69 months). The endpoint of the study was
overall survival after diagnosis starting at baseline
echocardiography; the endpoint was analyzed under
medical management, and under medical and surgical
management.
STATISTICAL ANALYSIS. Continuous variables were
expressed as mean  1 SD or medians and inter-
quartile ranges, and categorical variables were
summarized as numbers and frequency percentages.
The relationship between baseline continuous
baseline variables and the 4 groups was explored
using 1-way analysis of variance (for normally
distributed variables) or Kruskal-Wallis tests (for
non-normally distributed variables). Pearson’s chi-
square statistic or Fisher’s exact test were used to
examine the association between the 4 groups and
baseline categorical variables. The signiﬁcance be-
tween mild-to-moderate aortic stenosis (referent
group) and the other groups was examined if there
was a signiﬁcant difference across categories. Indi-
vidual differences were compared with Mann-
Whitney U tests (with Bonferroni correction for
multiple comparisons) and Tukey tests for normally
distributed data.
For analysis of outcomes under medical manage-
ment, data were censored at the time of cardiac sur-
gery (if performed). The entire follow-up was used to
analyze outcomes under conservative and surgical
treatments. The effect of surgery on outcome was
analyzed as a time-dependent covariate using the
entire follow-up (18). Survival rates  1 SE of the 4
groups were estimated according to the Kaplan-Meier
method and compared with 2-sided log-rank tests.
Multivariable analyses of all-cause mortality were
performed using Cox proportional hazards models.
The risk of death in the 3 severe aortic stenosis groups
(LG/LF aortic stenosis, LG/NF aortic stenosis, and HG
aortic stenosis) was estimated versus the referentgroup. We did not use model-building techniques,
and entered covariates were considered of potential
prognostic impact on an epidemiological basis in the
models. These covariates were age, sex, body surface
area, the comorbidity index, symptoms at baseline,
CAD, history of atrial ﬁbrillation, and EF. The pro-
portional hazards assumption was conﬁrmed using
statistics and graphs on the basis of Schoenfeld
residuals. All p values were results of 2-tailed tests.
Data were analyzed with SPSS version 13.0 (SPSS Inc.,
Chicago, Illinois) and STATA (version 12, StataCorp
LP, College Station, Texas). The authors had full
access to the data and take responsibility for its
integrity. All authors read and agreed to this paper as
written.
RESULTS
BASELINE CHARACTERISTICS. The baseline de-
mographic and clinical characteristics of the 809 pa-
tients with aortic stenosis are displayed in Table 1.
Patients with LG aortic stenosis were older than those
with mild-to-moderate aortic stenosis, were more
often women, and had lower body surface areas
(Table 1). The proportion of patients with New York
Heart Association functional class III or IV symptoms
at baseline was comparable between LG/LF aortic
stenosis and moderate aortic stenosis. The comor-
bidity index was higher in LF/LG aortic stenosis
patients compared with mild-to-moderate aortic
stenosis patients, and lower in HG aortic stenosis
patients (Table 1).
Baseline echocardiography data are summarized
in Table 2. Compared with mild-to-moderate aortic
stenosis, patients with LG/LF aortic stenosis had
higher MDG and peak aortic velocity, and smaller
SV, and less cardiac output. Left ventricular mass
was comparable between LG/LF aortic stenosis
and mild-to-moderate aortic stenosis (Table 2). HG
aortic stenosis was associated with a signiﬁcantly
greater degree of ventricular hypertrophy than mild-
to-moderate aortic stenosis (Table 2).
Outcome under medica l management . In 588 pa-
tients (73%), management was solely medical. Eighty
seven percent of LG/LF aortic stenosis patients pre-
senting with symptoms at baseline were treated
medically. Overall, crude 4-year mortality with med-
ical management was similar for the 4 study groups:
28  3% for mild-to-moderate aortic stenosis, 34  8%
for LG/LF aortic stenosis, 29  7% for LG/NF aortic
stenosis, and 31  5% for HG aortic stenosis
(Figure 1A).
On multivariable analysis (Table 3, Figure 2A),
comparedwith the reference category (mild-to-moderate
TABLE 1 Baseline Demographic and Clinical Characteristics of the 4 Groups of Patients With Aortic Stenosis
All Patients
(N ¼ 809)
Group
p Value
Moderate AS
(n ¼ 420)
LG/LF AS
(n ¼ 57)
LG/NF AS
(n ¼ 85)
HG AS
(n ¼ 247)
Demographics, baseline, data and symptoms
Age, yrs 77.4 (69.3–83.5) 76.9 (67.4–83.2) 78.5 (73.5–86.3)* 79.3 (73.9–83.9)* 76.9 (67.9–83.1) 0.009
Male 428 (53.0) 249 (59.3) 24* (42.1) 33* (38.8) 122 (49.4) 0.001
Body surface area, m2 1.90  0.23 1.94  0.22 1.86  0.21* 1.78  0.23† 1.88  0.24 <0.001
Systolic blood pressure, mm Hg 140.0 (125.0–150.0) 140.0 (125.0–150.0) 140.0 (120.0–156.0) 140.0 (130.0–150.0) 138.0 (120.0–150.0) 0.65
NYHA functional class III–IV symptoms 128 (15.8) 59 (14.0) 9 (15.8) 6 (7.1) 54* (21.9) 0.005
NYHA functional class
I 360 (44.5) 196 (46.7) 25 (43.9) 42 (49.4) 97 (39.3) 0.07
II 321 (39.7) 165 (39.3) 23 (40.4) 37 (43.5) 96 (38.9)
III 99 (12.2) 46 (11.0) 8 (14.0) 6 (7.1) 39 (15.8)
IV 29 (3.6) 13 (3.1) 1 (1.8) 0 (0) 15 (6.1)
Medical history and risk factors
Hypertension 583 (72.1) 316 (75.2) 40 (70.2) 65 (76.5) 162* (65.6) 0.043
Smoking 225 (27.8) 126 (30.0) 14 (24.6) 19 (22.4) 66 (26.7) 0.44
Dyslipidemia 343 (42.4) 186 (44.3) 16 (28.1) 36 (42.4) 105 (42.5) 0.14
Diabetes mellitus 243 (30.0) 138 (32.9) 20 (35.1) 21 (24.7) 64 (25.9) 0.11
Coronary artery disease 265 (32.8) 126 (30.0) 22 (38.6) 28 (32.9) 89 (36.0) 0.31
History of atrial ﬁbrillation 266 (32.9) 146 (34.8) 22 (38.6) 27 (31.8) 71 (28.7) 0.36
Charlson comorbidity index 2.0 (1.0–3.0) 2.0 (1.0–4.0) 2.0 (1.0–4.0) 2.0 (1.0–3.0) 1.0† (1.0–2.0) <0.001
Values are median (interquartile range), n (%), or mean  1 SD. *p < 0.05 individual category versus moderate AS. †p < 0.001 individual category versus moderate AS.
AS ¼ aortic stenosis; HG ¼ high-gradient; LF ¼ low-ﬂow; LG ¼ low-gradient; LV ¼ left ventricular; NF ¼ normal-ﬂow; NYHA ¼ New York Heart Association.
Tribouilloy et al. J A C C V O L . 6 5 , N O . 1 , 2 0 1 5
Low-Gradient, Low-Flow Severe Aortic Stenosis With Normal EF J A N U A R Y 6 / 1 3 , 2 0 1 5 : 5 5 – 6 6
58aortic stenosis), the 2 LG groups did not exhibit excess
mortality risk with medical treatment (adjusted hazard
ratio [HR]: 0.88; 95% conﬁdence interval [CI]: 0.53 to
1.48 for LG/LF aortic stenosis vs. mild-to-moderate
aortic stenosis, and adjusted HR: 1.06; 95% CI: 0.66
to 1.71 for LG/NF aortic stenosis vs. mild-to-moderate
aortic stenosis). In contrast, HG aortic stenosis pa-
tients were at higher risk of death than those with
mild-to-moderate aortic stenosis (adjusted HR: 1.47;
95% CI: 1.03 to 2.07). When only patients without
symptoms at baseline were considered, the same
mortality risk pattern was observed: patients with
mild-to-moderate aortic stenosis, LG/LF aortic stenosis,
and LG/NF aortic stenosis had comparable risks of
death (adjusted HR: 0.89; 95% CI: 0.53 to 1.49 for
LG/LF aortic stenosis vs. mild-to-moderate aortic
stenosis, and adjusted HR: 1.06; 95% CI: 0.66 to 1.70
for LG/NF aortic stenosis vs. mild-to-moderate aortic
stenosis). HG aortic stenosis patients were at signiﬁ-
cantly higher risk of death than patients with mild-to-
moderate aortic stenosis (adjusted HR: 1.44; 95% CI:
1.02 to 2.04). Among symptomatic patients, patients
with HG aortic stenosis had excess mortality under
medical management compared with mild-to-moderate
aortic stenosis (adjusted HR: 1.58; 95% CI: 1.02 to
2.48), whereas patients with LF/LG aortic stenosis andLG/NF aortic stenosis exhibited similar risks of death
compared with mild-to-moderate aortic stenosis
(adjusted HR: 1.29; 95% CI: 0.63 to 2.63 for LG/LF
aortic stenosis, and adjusted HR: 1.08; 95% CI: 0.54
to 2.16 for LG/NF aortic stenosis). The outcome of
symptomatic LF/LG aortic stenosis was not signiﬁ-
cantly different compared with asymptomatic moder-
ate aortic stenosis (adjusted HR: 1.01; 95% CI: 0.50
to 2.04).
Outcome with medical and surgical management. AVR
was eventually performed in 221 patients (27%),
according to the decision of the patient’s physician.
Aortic bioprostheses were used in 79% of cases
(n ¼ 174), and 67 patients had at least 1 associated
bypass graft at the time of surgery. Compared with
patients in whom management was exclusively
medical, patients who underwent AVR were younger
(p < 0.001), had lower Charlson indexes (p < 0.001),
smaller AVAs (p < 0.001), higher MDGs (p < 0.001),
and greater indexed left ventricular masses
(p ¼ 0.023). Surgical patients were more often men
(p ¼ 0.039) and more frequently had CAD (p < 0.001).
Although 53% (n ¼ 130) of patients with HG aortic
stenosis had AVR during follow-up, this decreased to
15% (n ¼ 63) in the mild-to-moderate aortic stenosis
TABLE 2 Echocardiographic Parameters of the 4 Groups of Patients With Aortic Stenosis
All Patients
(N ¼ 809)
Group
p Value
Moderate AS
(n ¼ 420)
LG/LF AS
(n ¼ 57)
LG/NF AS
(n ¼ 85)
HG AS
(n ¼ 247)
Aortic valve
Aortic valve area, cm2 1.0 (0.8–1.3) 1.3 (1.1–1.5) 0.8* (0.7–0.9) 0.9 (0.8–0.9) 0.7* (0.6–0.8) <0.001
Indexed aortic valve area, cm2/m2 0.5 (0.4–0.7) 0.7 (0.6–0.8) 0.4* (0.3–0.5) 0.5* (0.4–0.5) 0.4* (0.3–0.4) <0.001
Peak aortic jet velocity, m/s 3.5 (2.8–4.2) 2.9 (2.5–3.3) 3.3* (2.9–3.7) 3.7* (3.5–3.9) 4.6* (4.2–5.0) <0.001
Transaortic mean pressure gradient, mm Hg 30.0 (19.0–43.5) 20.0 (15.0–27.0) 30.0* (20.5–34.5) 34.0* (30.0–37.0) 53.0* (45.0–65.0) <0.001
Aortic valve velocity–time integral, cm 80.0 (62.0–100.0) 65.0 (55.0–78.0) 73.0 (66.0–80.0) 90.0* (82.0–100.5) 110.0* (96.0–125.0) <0.001
Dimensionless index <0.001
Valvuloarterial impedance, mm Hg/ml/m2 0.26 (0.20–0.34) 0.33 (0.28–0.40) 0.24* (0.20–0.27) 0.24* (0.21–0.26) 0.19* (0.16–0.22) <0.001
Cardiac output
LV outﬂow tract diameter, mm 22.0 (20.5–23.0) 22.0 (21.0–24.0) 20.0 (19.3–21.8)† 21.0 (20.0–22.8)† 21.5* (20.0–23.0) <0.001
LV outﬂow tract velocity–time integral, cm 21.0 (18.0–24.0) 22.0 (19.0–24.0) 16.7* (15.0–18.0) 22.0 (19.5–24.0) 21.0† (18.0–24.0) <0.001
Stroke volume, ml 78.9 (65.2–91.7) 83.6 (71.3–98.8) 54.4* (49.2–60.8) 75.4† (68.5–83.7) 75.9* (62.3–90.0) <0.001
Indexed stroke volume, ml/m2 41.7 (34.7–48.3) 43.7 (37.0–50.4) 30.1 (27.2–32.2)† 42.4 (39.0–45.4) 41.0 (33.5–48.0)* <0.001
Cardiac output, ml/min 5.7 (4.7–6.8) 6.1 (5.1–7.1) 4.29  0.71† 5.5† (4.8–6.5) 5.5* (4.5–6.4) <0.001
LV function
LV end-diastolic diameter, mm 49.0 (45.0–53.0) 50.0 (45.0–53.0) 47.0 (43.0–54.0) 48.0 (43.0–52.0) 49.0 (44.0–53.0) 0.09
LV end-systolic diameter, mm 30.0 (26.0–34.0) 30 (26.0–34.0) 32.0 (24.5–36.5) 29.0 (26.0–32.0) 30.0 (26.2–35.0) 0.12
LV end-diastolic septum thickness, mm 13.0 (11.0–14.0) 12.0 (11.0–14.0) 12.5 (10.0–14.0) 12.0 (11.0–13.3) 13.0* (12.0–15.0) <0.001
LV end-diastolic posterior wall thickness, mm 11.0 (9.0–12.0) 11.0 (9.0–12.0) 10.0 (9.0–12.0) 11.0 (9.0–12.0) 12.0* (10.0–13.0) <0.001
Fractional shortening, % 33.7  10.1 34.7  8.1 30.8  7.6 30.1  9.0 33.5  10.1 0.12
Ejection fraction, % 65.0 (59.0–69.0) 64.0 (59.0–68.0) 60.0† (55.0–67.0) 65.0 (60.0–69.0) 65.0 (59.0–70.0) 0.009
LV mass, g 213.9 (175.8–266.2) 207.3 (173.5–256.7) 213.3 (149.9–268.0) 200.5 (147.9–248.5) 232.9* (188.0–284.3) 0.001
Indexed LV mass, g/m2 113.7 (93.1–139.8) 107.8 (91.2–129.4) 111.2 (87.5–138.2) 112.6 (86.6–137.1) 125.5* (104.9–151.8) <0.001
Other parameters
Left atrial diameter, mm 40.9  7.5 40.7  6.7 41.0  8.1 40.7  7.5 41.1  7.3 0.97
Left atrial surface, cm2 23.4  6.3 22.7  5.7 24.3  7.2 23.1  7.5 23.9  6.2 0.30
Systolic pulmonary artery pressure, mm Hg 31.0 (26.0–39.0) 30.5 (26.0–38.0) 35.0 (27.8–45.0) 31.0 (28.0–40.8) 32.0 (27.0–39.0) 0.08
Values are median (interquartile range) or mean  1 SD . *p < 0.001 individual category versus moderate AS. †p < 0.05 individual category versus moderate AS.
Abbreviations as in Table 1.
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59group. Only 12% (n ¼ 7) of the LG/LF aortic stenosis
group and 25% (n ¼ 21) of the LG/NF aortic stenosis
group underwent surgery.
The crude 4-year estimates of mortality under
medical and surgical treatment were 28  2% for
mild-to-moderate aortic stenosis, 35  7% for LG/LF
aortic stenosis, 29  6% for LG/NF aortic stenosis,
and 29  3% for HG aortic stenosis (Figure 1B). On
multivariable analysis (Table 3, Figure 2B), the
outcome of HG aortic stenosis was poorer than that
of mild-to-moderate aortic stenosis (adjusted HR:
1.74; 95% CI: 1.27 to 2.39), whereas the outcome of
LG/LF aortic stenosis and LG/NF aortic stenosis did
not differ signiﬁcantly from that of mild-to-moderate
aortic stenosis (Table 3, Figure 2B). When the analysis
was limited to asymptomatic patients, HG aortic ste-
nosis was associated with greater risk than mild-to-
moderate aortic stenosis (adjusted HR: 2.52; 95% CI:
1.48 to 4.30). LG/LF aortic stenosis (adjusted HR:0.78; 95% CI: 0.38 to 1.62) and LG/NF aortic stenosis
(adjusted HR: 1.73; 95% CI: 0.94 to 3.17) did not show
signiﬁcant outcome differences compared with mild-
to-moderate aortic stenosis. Among patients with
symptoms, patients with LG/LF aortic stenosis and
LG/NF aortic stenosis had similar outcomes compared
with patients with mild-to-moderate aortic stenosis
(adjusted HR: 1.30; 95% CI: 0.43 to 3.94 for LG/LF
aortic stenosis, and adjusted HR: 0.51; 95% CI: 0.10 to
3.87 for LG/NF aortic stenosis), whereas patients with
HG aortic stenosis had excess mortality risk (adjusted
HR: 1.54: 95% CI: 1.03 to 2.30). Under medical and
surgical management, symptomatic LF/LG aortic
stenosis showed no excess mortality risk compared
with asymptomatic moderate aortic stenosis
(adjusted HR: 1.13; 95% CI: 0.59 to 2.14).
EFFECT OF SURGERY. Using surgery as a time-
dependent variable, the beneﬁt of surgery in the
FIGURE 1 Kaplan-Meier Mortality Curves of the 4 Groups of AS Patients
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60total study population was important (adjusted HR:
0.49; 95% CI: 0.35 to 0.68). Figure 3 depicts the
overall beneﬁt of surgery in patients with severe
aortic stenosis. On multivariable analysis, there was a
signiﬁcant interaction between the aortic stenosis
group classiﬁcation and the magnitude of survival
beneﬁt after surgery (p for interaction ¼ 0.022). The
beneﬁt associated with AVR was conﬁned to the HG
aortic stenosis group and was not signiﬁcant in the
other groups (Figure 4).
DISCUSSION
Our analysis of a large cohort of aortic stenosis pa-
tients with long-term follow-up puts into perspective
the various ﬂow-gradient patterns with regard to
natural history and management. Mild-to-moderate
aortic stenosis, LG aortic stenosis, and HG aortic ste-
nosis display comparable long-term crude mortality
with conservative therapy, as well as with medical
and surgical management. After taking age, comor-
bidity, and other factors with prognostic implica-
tions into account, LG/LF aortic stenosis has a ratherbenign outcome under medical management, despite
the symptomatic status. The natural history of LG/LF
aortic stenosis appears similar to that of moderate
aortic stenosis (Central Illustration). In contrast, re-
gardless of management, HG aortic stenosis shows
excess mortality compared with mild-to-moderate
aortic stenosis. Finally, AVR is associated with im-
proved outcome in HG aortic stenosis, but it
does not signiﬁcantly affect mortality in LG aortic
stenosis.
The entity of “paradoxical” LG/LF aortic stenosis
despite preserved EF was ﬁrst described in 2007 (3).
LG/LF aortic stenosis is diagnosed in patients pre-
senting with an AVA of <1 cm2, an indexed AVA
of <0.6 cm2/m2, an EF of >50%, and a MDG
of <40 mm Hg in the setting of a low-ﬂow (SV
index <35 ml/m2) state (3,8). Carefully conducted
invasive hemodynamics studies subsequently con-
ﬁrmed the existence of this entity (19,20). Its prev-
alence varies widely (between 3% and 24%) in
published reports (3–5,7). Patients with LG/LF aortic
stenosis are typically women, elderly, and have
more severe concentric left ventricular hypertrophy,
TABLE 3 Relative Risk of All-Cause Mortality in Patients With
Severe Aortic Stenosis (LG/LF, LG/NF, and HG) Compared With
Moderate Aortic Stenosis
Multivariable Model HR (95% CI) p Value
All-Cause Mortality With Medical Management
Model 1
Moderate AS Referent
LG/LF AS 0.88 (0.53–1.47) 0.63
LG/NF AS 1.06 (0.67–1.70) 0.79
HG AS 1.41 (1.01–1.99) 0.04
Model 2
Moderate AS Referent
LG/LF AS 0.88 (0.53–1.48) 0.65
LG/NF AS 1.06 (0.66–1.71) 0.81
HG AS 1.47 (1.03–2.07) 0.032
All-Cause Mortality With Medical and Surgical Management*
Model 1
Moderate AS Referent
LG/LF AS 0.95 (0.59–1.52) 0.83
LG/NF AS 1.09 (0.71–1.66) 0.69
HG AS 1.69 (1.24–2.30) 0.001
Model 2
Moderate AS Referent
LG/LF AS 0.96 (0.58–1.53) 0.82
LG/NF AS 1.07 (0.69–1.65) 0.75
HG AS 1.74 (1.27–2.39) 0.001
Model 1 is adjusted for age and Charlson comorbidity index. Model 2 is adjusted for
age, gender, Charlson comorbidity index, symptoms, coronary artery disease,
history of atrial ﬁbrillation, left ventricular ejection fraction, and body surface area.
*Analysis of mortality with medical and surgical management also includes surgery
as a time-dependent covariate.
CI ¼ conﬁdence interval; HR ¼ hazard ratio; other abbreviations as in Table 1.
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61small cavity size, impaired ventricular ﬁlling, and an
increased global hemodynamic load (3,4,8,10). For
Dumesnil et al. (8,21), LG/LF aortic stenosis repre-
sents the most advanced stage of aortic stenosis with
preserved EF. Nevertheless, more advanced disease
at presentation does not necessarily imply a temporal
relationship, for example, that HG aortic stenosis
progresses to LG/LF aortic stenosis. Subsequently,
severe LG aortic stenosis was frequently observed
among patients with a preserved EF and NF (SV
index $35 ml/min) and was interpreted mainly in
relation to measurement errors or inconsistencies in
the guidelines criteria (6,20). A new 4-group classiﬁ-
cation of aortic stenosis according to MDG and ﬂow
criteria was proposed in 2010 (8).
The prognosis of LG/LF aortic stenosis is the
subject of an ongoing debate. Several studies have
shown that patients with LG/LF aortic stenosis have
a pejorative survival compared with both moderate
aortic stenosis and HG aortic stenosis (3–5,7,22).
Among 150 asymptomatic patients with severe
aortic stenosis, LF/LG was identiﬁed as independentdeterminant of reduced event-free survival (4).
Clavel et al. (5) used retrospective matching to
compare the outcomes of LG/LF aortic stenosis,
moderate aortic stenosis, and HG aortic stenosis, and
reported a 1.71-fold increase in the adjusted risk of
all-cause death and a 2.09-fold increase in the
adjusted risk of cardiovascular death for LG/LF
aortic stenosis compared with a pooled population of
moderate aortic stenosis and HG aortic stenosis.
Ozkan et al. (22) reported a 53% mortality rate for
symptomatic LG aortic stenosis patients who were
managed medically, with similar outcomes for pa-
tients with LG/LF aortic stenosis and LG/NF aortic
stenosis who were under medical therapy. In
this series, the outcome of LG aortic stenosis
signiﬁcantly improved with AVR (22). Finally, Eleid
et al. (7) showed that the LG/LF pattern signiﬁcantly
increased the risk of death, whereas AVR had a
markedly protective effect.
This perspective was questioned by a report from
the SEAS trial that compared the long-term outcome
of 2 asymptomatic subsets of aortic stenosis patients:
184 patients with moderate aortic stenosis and 435
patients with LG severe aortic stenosis (14). Out-
comes, with regard to valve-related events, major
cardiovascular events, or cardiac death during long-
term follow-up, did not signiﬁcantly differ between
the 2 groups (14). Both groups had better prognoses
than patients with HG aortic stenosis. This report (14)
was criticized for analyzing a low-risk population
that did not display typical features of LG/LF aortic
stenosis, and was considered ﬂawed by measurement
errors, use of nonindexed AVA, and inconsistency of
guideline criteria (21). Despite these arguments, we
believe that these randomized trial data are not
biased by confounding factors, such as poor func-
tional status, symptoms and comorbidities, which
play a major role when discussing surgery for LG/LS
severe aortic stenosis. Recently, in a cohort of pa-
tients with severe aortic stenosis and preserved EF,
Maes et al. reported better outcomes under medical
management for patients with LG aortic stenosis
compared with patients with HG stenosis, and
observed that >80% of patients with LG aortic ste-
nosis exhibited signiﬁcant increases in MDG during
follow-up (15).
Our results showed that the long-term outcome
of the LG/LF pattern is similar to that of mild-to-
moderate aortic stenosis, regardless of the manage-
ment type and symptomatic status; therefore, LG/LF
aortic stenosis does not represent a more advanced
stage of the disease. This result should be interpreted
with some important considerations kept in mind.
First, we separated LG aortic stenosis into LG/LF and
FIGURE 2 Adjusted Mortality Curves for the 4 Groups of AS Patients
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62LG/NF aortic stenosis, included the indexed AVA to
deﬁne severe LG/LF aortic stenosis, calculated the
index SV according to guideline criteria (1,2), and
in survival analyses, we systematically took bodyFIGURE 3 Comparison Between Adjusted Mortality Curves of
Patients With Severe AS With Surgical (AVR) Versus
Medical Management
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Medical therapy
Adjusted for age, sex, body surface area, comorbidity, symptoms,
coronary artery disease, atrial ﬁbrillation, and ejection fraction.
AVR ¼ aortic valve replacement; HR ¼ hazard ratio; other
abbreviations as in Figure 1.surface area into account. Second, we aimed to
investigate the natural history of LG/LF aortic steno-
sis by allowing a medical management period of at
least 3 months after diagnosis (15). In our opinion,
this approach reduced surgery-related biases by
eliminating patients with severe aortic stenosis who,
because of severe symptoms, were operated on
immediately after diagnosis. Third, older retrospec-
tive series of LG/LF aortic stenosis did not report
the symptomatic status of the patients (3), whereas
more recent series included either asymptomatic in-
dividuals (4,14) or patients with severe symptoms
(22). Our study included the entire symptomatic
spectrum of aortic stenosis, and the similar outcomes
for LG/LF aortic stenosis and mild-to-moderate aortic
stenosis observed in the overall population were
conﬁrmed in the subgroup of patients who were
asymptomatic at baseline. Fourth, in contrast to
previous studies that used composite endpoints
(4,14), our study focused on all-cause death and
analyzed AVR with a time-dependent methodology.
We believe that AVR is not an appropriate endpoint in
this type of analysis, because it is mainly the result of
the physician’s assessment of the severity of the
disease. For all survival analyses, we took into ac-
count age and comorbidities that signiﬁcantly
affected outcome and played major roles in the de-
cision for surgery. Finally, aortic stenosis severity
might be underestimated when the right parasternal
window is not used for recording the continuous
FIGURE 4 Comparison Between Adjusted Mortality Curves of Each of the 4 Groups of AS Patients With Surgical (AVR) Versus
Medical Management
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63Doppler ﬂow across the aortic valve. On the other
hand, underestimation of the diameter of the left
ventricular outﬂow tract might lead to an over-
estimation of the severity of the disease (20). In our
study, we systemically performed careful measure-
ments of the outﬂow tract diameter in zoomed para-
sternal views and multiple acoustic windows for
continuous-wave Doppler, including the right para-
sternal window. Nevertheless, despite rigorous
echocardiographic evaluation and use of currently
accepted deﬁnitions for LG/LF severe aortic stenosis,
inherent errors in measurement might have led to
some misclassiﬁcation of mild-to-moderate aortic
stenosis into LG/LF severe aortic stenosis.Our survival data were in accordance with recent
anatomical and morphological data (16,23,24). In a
population of patients with severe aortic stenosis and
preserved EFs, magnetic resonance imaging showed
larger AVAs, a lower degree of ventricular hypertro-
phy, and similar focal ﬁbrosis in the LG/LF subgroup
compared with the HG aortic stenosis subgroup (15).
Moreover, compared with HG aortic stenosis, the
aortic valves of patients with LG/LF aortic stenosis
had lower weights (23) and showed less severe calci-
ﬁcation (24).
With regard to surgery, previous series (5,7,14)
suggested that LG/LF aortic stenosis has a pejorative
prognosis when treated conservatively, and that AVR
CENTRAL ILLUSTRATION Long-Term Outcome of Low-Gradient Aortic Stenosis, Moderate Aortic Stenosis, and
High-Gradient Aortic Stenosis Under Medical Management
Under medical management, the outcome for low-gradient/low-ﬂow aortic stenosis with preserved ejection fraction is similar to that of
moderate aortic stenosis and poorer compared with high-gradient aortic stenosis.
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64signiﬁcantly improves the outcome. In our series,
although AVR was associated overall with marked
mortality reduction in the population with severe
aortic stenosis, we did not observe any signiﬁcant
beneﬁcial effect in the subset with LG/LF aortic
stenosis.
STRENGTHS AND LIMITATIONS. Our study had the
inherent limitations of retrospective analyses. How-
ever, cardiologists with expertise in valvular disease
performed diagnosis and follow-up, and surgical
decisions were made by the heart team with the
approval of the patients’ physicians, in accordance
with current practice guidelines. The speciﬁc in-
dications for surgery during follow-up were not
collected in our database. Our study was not a
prevalence study, because patients were recruited
at the echocardiography laboratory, and we excluded
patients who were operated on during the ﬁrst
3 months after diagnosis. We acknowledge that therelatively small number of patients with LF/LG aortic
stenosis represented a limitation, and that the rela-
tionship between surgery and outcome in the LG
subgroups should be interpreted with caution. The
multivariable model that investigated the effect of
surgery in LG/LF aortic stenosis might be overﬁtted,
and the result should be viewed as exploratory.
Further studies with larger numbers of LG/LF aortic
stenosis patients are needed to deﬁnitively establish
the impact of surgery in LG/LF aortic stenosis.
Censoring the patients who were initially managed
conservatively at the time of surgery did not account
for the beneﬁt and/or risk of waiting. Despite system-
atic adjustment for CAD in multivariable analyses,
CAD severity and revascularization status might in-
crease the heterogeneity of the population and affect
outcomes. Finally, this study did not use hemody-
namic parameters, which might have allowed more
precise classiﬁcation of the ﬂow-gradient patterns.
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE: Irrespective of
management, LG/LF severe aortic stenosis with preserved EF is
associated with outcomes similar to those of moderate aortic
stenosis.
COMPETENCY IN MEDICAL CARE: Patients with asymptom-
atic severe LG/LF aortic stenosis with preserved EF must be fol-
lowed carefully and closely for symptoms due to the valve lesions,
and surgery must be discussed when these symptoms develop.
TRANSLATIONAL OUTLOOK: Prospective studies are needed
to clarify the beneﬁt of surgery for patients with LG/LF severe
aortic stenosis with preserved EF and whether the natural history
and approach to management vary for patients on the basis of
speciﬁc ﬂow-gradient patterns associated with valvular aortic
stenosis.
J A C C V O L . 6 5 , N O . 1 , 2 0 1 5 Tribouilloy et al.
J A N U A R Y 6 / 1 3 , 2 0 1 5 : 5 5 – 6 6 Low-Gradient, Low-Flow Severe Aortic Stenosis With Normal EF
65CONCLUSIONS
Across the spectrum of aortic stenosis severity, LG/LF
aortic stenosis does not represent the ﬁnal stage of
the disease, and has a more favorable outcome
compared with HG aortic stenosis. In our series,
despite the management type and symptomatic sta-
tus, the mortality risk of LG/LF aortic stenosis was
similar to that of mild-to-moderate aortic stenosis
and did not appear to be signiﬁcantly improved by
AVR. According to current guidelines (25), the surgi-
cal decision in LG/LF aortic stenosis should be dis-
cussed only for symptomatic patients. Such decisions
should be made cautiously on a case-by-case basis
when there is evidence that symptoms are most likely
due to valve stenosis (1,25) and after documenting the
severity of the stenosis and signiﬁcant valvular cal-
ciﬁcations. However, symptoms are often difﬁcult to
interpret, because these patients are elderly, and
have CAD, atrial ﬁbrillation, and important comor-
bidities. Measuring brain natriuretic peptide levels
may be helpful in difﬁcult cases. Because of the
intense debate about the indication for AVR in pa-
tients with LG/LF aortic stenosis with preserved EF,
the natural history and the impact of AVR in LG/LF
aortic stenosis deserve future, carefully designed,
large, prospective studies.REPRINT REQUESTS AND CORRESPONDENCE: Dr.
Christophe Tribouilloy, INSERM, U-1088, University
Hospital Amiens, Department of Cardiology, Avenue
René Laënnec, 80054 Amiens Cedex 1, France.
E-mail: tribouilloy.christophe@chu-amiens.fr.RE F E RENCE S1. Bonow RO, Carabello BA, Chatterjee K, et al.
ACC/AHA 2006 guidelines for the management
of patients with valvular heart disease: a report
of the American College of Cardiology/American
Heart Association Task Force on Practice Guide-
lines (Writing Committee to Revise the 1998
guidelines for the management of patients with
valvular heart disease) developed in collabora-
tion with the Society of Cardiovascular Anes-
thesiologists endorsed by the Society for
Cardiovascular Angiography and the Society of
Thoracic Surgeons. J Am Coll Cardiol 2006;48:
e1–148.
2. Joint Task Force on the Management of
Valvular Heart Disease of the European Soci-
ety of Cardiology (ESC); European Association
for Cardio-Thoracic Surgery (EACTS),
Vahanian A, Alﬁeri O, Andreotti F, et al.
Guidelines on the management of valvular
heart disease (version 2012). Eur Heart J
2012;33:2451–96.
3. Hachicha Z, Dumesnil JG, Bogaty P, et al.
Paradoxical low-ﬂow, low-gradient severe
aortic stenosis despite preserved ejection
fraction is associated with higher afterload and
reduced survival. Circulation 2007;115:
2856–64.
4. Lancellotti P, Magne J, Donal E, et al. Clinical
outcome in asymptomatic severe aortic stenosis:
insights from the new proposed aortic stenosisgrading classiﬁcation. J Am Coll Cardiol 2012;59:
235–43.
5. Clavel MA, Dumesnil JG, Capoulade R, et al.
Outcome of patients with aortic stenosis, small
valve area, and low-ﬂow, low-gradient despite
preserved left ventricular ejection fraction. J Am
Coll Cardiol 2012;60:1259–67.
6. Minners J, Allgeier M, Gohlke-Baerwolf C, et al.
Inconsistent grading of aortic valve stenosis by
current guidelines: haemodynamic studies in
patients with apparently normal left ventricular
function. Heart 2010;96:1463–8.
7. Eleid MF, Sorajja P, Michelena HI, et al. Flow-
gradient patterns in severe aortic stenosis with pre-
served ejection fraction: clinical characteristics and
predictors of survival. Circulation 2013;128:1781–9.
8. Dumesnil JG, Pibarot P, Carabello B. Paradoxi-
cal low ﬂow and/or low gradient severe aortic
stenosis despite preserved left ventricular ejection
fraction: implications for diagnosis and treatment.
Eur Heart J 2010;31:281–9.
9. Pibarot P, Dumesnil JG. Paradoxical low-ﬂow,
low-gradient aortic stenosis adding new pieces to
the puzzle. J Am Coll Cardiol 2011;58:413–5.
10. Cramariuc D, Ciofﬁ G, Rieck AE, et al. Low-
ﬂow aortic stenosis in asymptomatic patients:
valvular-arterial impedance and systolic function
from the SEAS Substudy. J Am Coll Cardiol Img
2009;2:390–9.11. Lancellotti P, Donal E, Magne J, et al. Impact of
global left ventricular afterload on left ventricular
function in asymptomatic severe aortic stenosis: a
two-dimensional speckle-tracking study. Eur J
Echocardiogr 2010;11:537–43.
12. Adda J, Mielot C, Giorgi R, et al. Low-ﬂow,
low-gradient severe aortic stenosis despite normal
ejection fraction is associated with severe left
ventricular dysfunction as assessed by speckle-
tracking echocardiography: a multicenter study.
Circ Cardiovasc Img 2012;5:27–35.
13. Herrmann S, Störk S, Niemann M, et al. Low-
gradient aortic valve stenosis myocardial ﬁbrosis
and its inﬂuence on function and outcome. J Am
Coll Cardiol 2011;58:402–12.
14. Jander N, Minners J, Holme I, et al. Outcome
of patients with low-gradient “severe” aortic ste-
nosis and preserved ejection fraction. Circulation
2011;123:887–95.
15. Maes F, Boulif J, Pierard S, et al. Natural his-
tory of paradoxical low gradient “severe” aortic
stenosis. Circ Cardiovasc Img 2014;7:714–22.
16. Barone-Rochette G, Piérard S, Seldrum S, et al.
Aortic valve area, stroke volume, left ventricular
hypertrophy, remodeling, and ﬁbrosis in aortic
stenosis assessed by cardiac magnetic resonance
imaging: comparison between high and low
gradient and normal and low ﬂow aortic stenosis.
Circ Cardiovasc Img 2013;6:1009–17.
Tribouilloy et al. J A C C V O L . 6 5 , N O . 1 , 2 0 1 5
Low-Gradient, Low-Flow Severe Aortic Stenosis With Normal EF J A N U A R Y 6 / 1 3 , 2 0 1 5 : 5 5 – 6 6
6617. Charlson ME, Pompei P, Ales KL, et al. A new
method of classifying prognostic comorbidity in
longitudinal studies: development and validation.
J Chronic Dis 1987;40:373–83.
18. Venables WN, Ripley BD. Modern Applied
Statistics with S-PLUS, 3rd ed. New York, NY:
Springer-Verlag, 1999:391–4.
19. Lauten J, Rost C, Breithardt OA, et al.
Invasive hemodynamic characteristics of low
gradient severe aortic stenosis despite preserved
ejection fraction. J Am Coll Cardiol 2013;61:
1799–808.
20. Minners J, Allgeier M, Gohlke-Baerwolf C,
et al. Inconsistencies of echocardiographic criteria
for grading of aortic valve stenosis. Eur Heart J
2008;29:1043–8.21. Dumesnil JG, Pibarot P. Low-ﬂow, low-
gradient severe aortic stenosis in patients with
normal ejection fraction. Curr Opin Cardiol 2013;
28:524–30.
22. Ozkan A, Hachamovitch R, Kapadia SR, et al.
Impact of aortic valve replacement on outcome of
symptomatic patients with severe aortic stenosis
with low gradient and preserved left ventricular
ejection fraction. Circulation 2013;128:622–31.
23. Clavel MA, Cote N, Mathieu P, et al. Paradox-
ical low-ﬂow, low-gradient aortic stenosis despite
preserved left ventricular ejection fraction: new
insights from weights of operatively excised aortic
valves. Eur Heart J 2014;35:2655–62.
24. Clavel MA, Messika-Zeitoun D, Pibarot P, et al.
The complex nature of discordant severe calciﬁedaortic valve disease grading: new insights from
combined Doppler echocardiographic and com-
puted tomographic study. J Am Coll Cardiol 2013;
62:2329–38.
25. Nishimura RA, Otto CM, Bonow RO, et al.
American College of Cardiology/American Heart
Association Task Force on Practice Guidelines.
2014 AHA/ACC Guideline for the management
of patients with valvular heart disease: a
report of the American College of Cardiology/
American Heart Association Task Force on
Practice Guidelines. J Am Coll Cardiol 2014;63:
e57–185.
KEY WORDS aortic valve, cardiac surgical
procedures, follow-up studies, mortality
